InvestSMART

WAM Strategic Value Limited (ASX:WAR)

ALERT: Price-sensitive ASX Announcement for WAR
Current share price for WAR : $1.090 -0.07 (-6.03%)+
Announcement
Release
21 Aug 2026 9:25AM
Price at Release
$1.160
Full Release
download
Summary
The document is the Appendix 4E and Annual Report for Memphasys Limited, detailing the financial performance and operations for the year ending 30 June 2025. The company reported a significant decline in revenue by 94% to $4,000 and total income by 47% to $532,000, with an increased loss from continuing operations by 11% to $4,942,000. No dividends were declared or paid during the period, and net tangible liabilities per ordinary security were reported at -0.2 cents. The company emphasized its strategic focus on the commercial rollout of its Felix™ System for addressing male fertility challenges. There were no new entities controlled during the period, and the financial statements are in the process of being audited.
Key Points
  • Revenue decreased by 94% to $4,000
  • Total income decreased by 47% to $532,000
  • Loss from continuing operations increased by 11% to $4,942,000
  • No dividends declared or paid during the period
  • Net tangible liabilities per ordinary security at -0.2 cents
  • Focus on commercial rollout of Felix™ System for male fertility
  • No entities gained control during the period
  • Financial statements are being audited
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.